Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dosimetry Trial of Holmium-166-DOTMP in Multiple Myeloma
NCT00039754Phase 2Terminated
- Sponsor
- Poniard Pharmaceuticals, Inc.
- Start
- Mar 2002
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of Holmium-166-DOTMP in multiple myeloma (MM), sponsored by Poniard Pharmaceuticals, Inc.. Started Mar 2002; status: terminated.
02
Drugs
Holmium-166-DOTMP
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT00039754.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00039754.